ID: ALA5266803

Max Phase: Preclinical

Molecular Formula: C21H28N2O4

Molecular Weight: 372.47

Associated Items:

Representations

Canonical SMILES:  O=c1cc(CNCc2ccc(OCCCN3CCCCC3)cc2)occ1O

Standard InChI:  InChI=1S/C21H28N2O4/c24-20-13-19(27-16-21(20)25)15-22-14-17-5-7-18(8-6-17)26-12-4-11-23-9-2-1-3-10-23/h5-8,13,16,22,25H,1-4,9-12,14-15H2

Standard InChI Key:  OMYLHUKQSKLRMY-UHFFFAOYSA-N

Associated Targets(Human)

Histamine H3 receptor 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.2049AlogP: 2.89#Rotatable Bonds: 9
Polar Surface Area: 74.94Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.69CX Basic pKa: 9.07CX LogP: 1.72CX LogD: -0.04
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.68

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source